Integrative Health Sciences Facility Core

综合健康科学设施核心

基本信息

项目摘要

Integrative Health Sciences Facility Core (IHSFC) Abstract The IHSFC supports all human research in the CEET. It is the entity that permits the CEET to attain its Strategic Vision to perform translational environmental health research that will impact patients, communities, and the public. It provides highly focused transdisciplinary services including study design, enrollment of subjects, data management, access to biological samples, biostatistical analyses, interpretation of results and dissemination of results to the public through the Community Outreach and Engagement Core (COEC). Over the past four years, the IHSFC has uniquely focused on delivery of five specific services that include: human studies design and performance services, human exposure laboratories, human population exposure services, CEET virtual biorepositories, and biostatistics support for both non-genomics and genomics studies. Each service provides CEET investigators with unique tools to translate fundamental research into improvements in individual human and population-based cohorts to advance PREcision Environmental Medicine (PREEM). In a bi-directional manner, the IHSFC communicates with the COEC to formulate community-based questions and concerns into specific hypotheses for investigators with expertise in population-based studies. An important goal of the IHSFC is to promote inter-Environmental Health Science Core Center (EHS CC) collaborative projects in human subjects. Over the past four years, five interactive projects involving inter-EHS CC pilot projects or R01 equivalents have been initiated. The interaction of the IHSFC with other centers greatly extends the expertise to a network of EHS CCs to address inter-center human research. As described in the Strategic Vision, the IHSFC supports integrated research themes in humans that transcend affinity groups and the formation of translational research teams that involve CEET investigators and COEC members to address community-based questions.
综合健康科学设施核心(IHSFC)摘要 IHSFC支持CEET的所有人类研究。它是使CEET能够实现其战略目标的实体。 愿景是进行转化环境健康研究,这将影响患者,社区和公众。 它提供高度集中的跨学科服务,包括研究设计,受试者招募,数据 管理、获取生物样本、生物统计分析、结果解释和 通过社区外展和参与核心(COEC)向公众公布结果。在过去的四年里, IHSFC专注于提供五项具体服务,包括:人类研究设计和 性能服务,人体暴露实验室,人群暴露服务,CEET虚拟 生物储存库和生物统计学支持非基因组学和基因组学研究。每项服务提供 CEET研究人员拥有独特的工具,可以将基础研究转化为个人的改善, 以人口为基础的队列,以推进PRECISE环境医学(PREEM)。以双向方式, IHSFC与COEC沟通,将基于社区的问题和关切制定为具体的 为具有人群研究专业知识的研究者提供假设。IHSFC的一个重要目标是 促进跨环境健康科学核心中心(EHS CC)在人类受试者的合作项目。超过 在过去的四年里,五个涉及跨EHS CC试点项目或R01等效项目的互动项目, 启动。IHSFC与其他中心的互动极大地扩展了EHS CC网络的专业知识, 解决中心间人类研究问题。正如战略愿景所述,IHSFC支持综合研究 超越亲和群体的人类主题和涉及翻译研究团队的形成 CEET调查人员和COEC成员解决基于社区的问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Reynold Alexander Panettieri其他文献

Reynold Alexander Panettieri的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Reynold Alexander Panettieri', 18)}}的其他基金

New Jersey Alliance for Clinical Translational Science: NJ ACTS
新泽西临床转化科学联盟:NJ ACTS
  • 批准号:
    10260091
  • 财政年份:
    2021
  • 资助金额:
    $ 28万
  • 项目类别:
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma
新型分子机制促进 GPCR 诱导的哮喘支气管扩张
  • 批准号:
    10478318
  • 财政年份:
    2021
  • 资助金额:
    $ 28万
  • 项目类别:
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma
新型分子机制促进 GPCR 诱导的哮喘支气管扩张
  • 批准号:
    10271810
  • 财政年份:
    2021
  • 资助金额:
    $ 28万
  • 项目类别:
New Jersey Alliance for Clinical Translational Science: NJ ACTS
新泽西临床转化科学联盟:NJ ACTS
  • 批准号:
    9890029
  • 财政年份:
    2019
  • 资助金额:
    $ 28万
  • 项目类别:
New Jersey Alliance for Clinical Translational Science: NJ ACTS
新泽西临床转化科学联盟:NJ ACTS
  • 批准号:
    10582591
  • 财政年份:
    2019
  • 资助金额:
    $ 28万
  • 项目类别:
New Jersey Alliance for Clinical Translational Science: NJ ACTS
新泽西临床转化科学联盟:NJ ACTS
  • 批准号:
    10201004
  • 财政年份:
    2019
  • 资助金额:
    $ 28万
  • 项目类别:
New Jersey Alliance for Clinical Translational Science: NJ ACTS
新泽西临床转化科学联盟:NJ ACTS
  • 批准号:
    10360219
  • 财政年份:
    2019
  • 资助金额:
    $ 28万
  • 项目类别:
New Jersey Alliance for Clinical Translational Science: NJ ACTS
新泽西临床转化科学联盟:NJ ACTS
  • 批准号:
    10360671
  • 财政年份:
    2019
  • 资助金额:
    $ 28万
  • 项目类别:
New Jersey Alliance for Clinical Translational Science: NJ ACTS
新泽西临床转化科学联盟:NJ ACTS
  • 批准号:
    10115156
  • 财政年份:
    2019
  • 资助金额:
    $ 28万
  • 项目类别:
Project 1 - TGF-beta1 directly modulates excitation-contraction signaling in airway smooth muscle to evoke airway hyperresponsiveness in asthma
项目 1 - TGF-β1 直接调节气道平滑肌中的兴奋收缩信号传导以引起哮喘气道高反应性
  • 批准号:
    10465060
  • 财政年份:
    2013
  • 资助金额:
    $ 28万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了